Alzheimer’s disease (AD) is a progressive neurodegenerative disorder, which is pathologically characterized by deposition of amyloid-beta peptide (Aβ), as well as hyperphosphorylated tau aggregation. This evidence concerns the gene APP and early-onset autosomal dominant Alzheimer disease.